35 results on '"B. Eliceiri"'
Search Results
2. 1540 Distinct leukocyte populations in the delayed wound healing phenotype of ECRG4 deficient mice
- Author
-
R.A. Dorschner, S. Sayeed, K. Pool, and B. Eliceiri
- Subjects
Cell Biology ,Dermatology ,Molecular Biology ,Biochemistry - Published
- 2023
3. 773 Acceleration of diabetic wound closure by rescue of deficient serpin inhibitor protein (SERPIN) in extracellular vesicles
- Author
-
D. Park, E. Duggan, R.A. Dorschner, M. Dobke, J. Nolan, and B. Eliceiri
- Subjects
Cell Biology ,Dermatology ,Molecular Biology ,Biochemistry - Published
- 2022
4. 796 ECRG4 regulates neutrophil responsiveness to proinflammatory signals during recruitment to infection
- Author
-
K.D. Pool, B. Eliceiri, and R.A. Dorschner
- Subjects
Cell Biology ,Dermatology ,Molecular Biology ,Biochemistry - Published
- 2022
5. IMMUNOLOGY RESEARCH
- Author
-
M. Barish, L. Weng, M. D'Apuzzo, S. Forman, C. Brown, I. Ben Horin, I. Volovitz, Z. Ram, A. Chang, D. Wainwright, M. Dey, Y. Han, M. Lesniak, K. Chow, J. Yi, D. Shaffer, S. Gottschalk, A. Clark, M. Safaee, T. Oh, M. Ivan, R. Kaur, M. Sun, Y.-J. Lu, T. Ozawa, C. D. James, O. Bloch, A. Parsa, W. Debinski, Y. A. Choi, D. M. Gibo, C. Herold-Mende, J. Mossemann, C. Jungk, R. Ahmadi, D. Capper, A. von Deimling, A. Unterberg, P. Beckhove, H. Jiang, S. R. Klein, S. Piya, L. Vence, W. K. A. Yung, R. Sawaya, A. Heimberger, C. Conrad, F. Lang, C. Gomez-Manzano, J. Fueyo, T.-Y. Jung, Y.-D. Choi, Y.-H. Kim, J.-J. Lee, H.-S. Kim, J.-S. Kim, S.-K. Kim, S. Jung, D. Cho, A. Kosaka, T. Ohkuri, H. Okada, K. Erickson, C. Malone, E. Ha, H. Soto, M. Hickey, G. Owens, L. Liau, R. Prins, B. Minev, C. Kruse, J. Lee, X. Dang, A. Borboa, R. Coimbra, A. Baird, B. Eliceiri, D. Mathios, M. Lim, J. Ruzevick, S. Nicholas, M. Polanczyk, C. Jackson, J. Taube, P. Burger, A. Martin, H. Xu, K. Ochs, F. Sahm, C. A. Opitz, T. V. Lanz, I. Oezen, P.-O. Couraud, W. Wick, M. Platten, A. Ghosh, J. Zhu, M. Ikeura, S. Watkins, S. Sarkar, S. Pellegatta, S. Pessina, G. Cantini, D. Kapetis, G. Finocchiaro, T. Avril, E. Vauleon, A. Hamlat, J. Mosser, V. Quillien, B. Raychaudhuri, P. Rayman, P. Huang, M. Grabowski, D. Hamburdzumyan, J. Finke, M. Vogelbaum, D. Renner, A. Litterman, A. Balgeman, F. Jin, L. Hanson, J. Gamez, B. Carlson, J. Sarkaria, I. Parney, J. Ohlfest, I. Pirko, K. Pavelko, A. Johnson, J. Sims, B. Grinshpun, Y. Feng, B. Amendolara, Y. Shen, P. Canoll, P. Sims, J. Bruce, S. X. Lee, E. Wong, K. Swanson, I. Balyasnikova, Y. Cheng, F. Wang, J. Wei, S. Xu, X. Ling, N. Yaghi, L.-Y. Kong, T. Doucette, J. Weinberg, F. DeMonte, S. Prabhu, J. Wiencke, W. Accomando, E. A. Houseman, H. Nelson, M. Wrensch, J. Wiemels, S. Zheng, G. Hsuang, P. Bracci, and K. Kelsey
- Subjects
Abstracts ,Cancer Research ,Oncology ,Neurology (clinical) - Published
- 2013
6. LIST OF CONTRIBUTORS
- Author
-
Adriano Aguzzi, Tamara Alliston, Ali Arslan, Indrani C. Bagchi, Milan K. Bagchi, C. Wayne Bardin, Craig L. Best, Julie A. Blendy, Martha M. Bosma, Eugene P. Brandon, Robert E. Braun, D.D. Brown, Nail Burnashev, Jean S. Campbell, Nicholas A. Cataldo, Kevin J. Catt, Pierre Chambon, Anne Charru, J.H. Check, Mitchell I. Chemin, Khoi Chu, James H. Clark, Jeffrey W. Clemens, Timothy J. Cole, Orla M. Conneely, Pierre Corvol, Tamás Csikós, Mark Danielsen, Ying Qing Ding, Carl Djerassi, B. Eliceiri, Adria A. Elskus, Satish A. Eraly, Mark A. Fajardo, Susan L. Fitzpatrick, Victor Y. Fujimoto, J.D. Furlow, Dana Gaddy-Kurten, Ruth Ganss, Frederick W. George, Kirstin A. Gerhold, Paul A. Godfrey, Jonathan D. Graves, Lee M. Graves, L. Earl Gray, Joseph A. Hill, Bertil Hille, Lyann R. Hodgskin, Edith Hummler, David L. Hurley, Rejean L. Idzerda, Robert B. Jaffe, Amy M. Jensen, Xavier Jeunemaitre, A. Kanamori, William R. Kelce, Hansjorg Keller, Paul A. Kelly, John Kirkland, Georg Köhr, Yuri Kotelevtsev, Edwin G. Krebs, David J. Kulik, Thomas Kuner, Agnès Larcher, Mark A. Lawson, Keesook Lee, Diana Lefèbvre, Joanna M. Makris, Shaila Mani, Kelly E. Mayo, G. Stanley McKnight, Jeffrey A. Medin, Pamela L. Mellon, Emily Monosson, Lluis Montoliu, Hannah Monyer, Jaqueline K. Morris, Patricia L. Morris, Lata Murthy, Lynne V. Nazareth, Susan B. Nunez, Bert W. O'Malley, Yoshihiro Okuda, Keiko Ozato, Kathleen Creed Page, Carol J. Phelps, Ming Qi, Jason O. Rahal, Marilyn B. Renfree, Stéphane Richard, JoAnne S. Richards, Mario I. Romero, Elliott M. Ross, Florence Rozen, Radmila Runic, Peter N. Schlegel, Wolfgang Schmid, William T. Schrader, Jill M. Schumacher, Günter Schütz, Neena B. Schwartz, R. Schwartzman, Peter H. Seeburg, James Segars, Rony Seger, B.S. Shanis, Jean Sirois, Carolyn Smith, Florent Soubrier, Rolf Sprengel, George Stancel, Stanko S. Stojilkovic, Steven T. Suhr, Joyce Tay, Vilmos Thomazy, E. Brad Thompson, Philippe Touraine, Amy Tse, Frederick W. Tse, Kunihiro Tsuchida, Wylie Vale, Walter Wahli, Ken Wang, Z. Wang, Nancy L. Weigel, David B. Whyte, Jean D. Wilson, Patrick W. Wojtkiewicz, Shimin Zhang, and Hans H. Zingg
- Published
- 1995
7. Fluoxetine reduces organ injury and improves motor function after traumatic brain injury in mice.
- Author
-
Weaver JL, Eliceiri B, and Costantini TW
- Subjects
- Animals, Disease Models, Animal, Fluoxetine pharmacology, Fluoxetine therapeutic use, Humans, Inflammation complications, Mice, Serotonin therapeutic use, Brain Injuries complications, Brain Injuries, Traumatic complications, Brain Injuries, Traumatic drug therapy
- Abstract
Background: Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in trauma patients worldwide. Brain injury is associated with significant inflammation, both within the brain and in the peripheral organs. This inflammatory response in TBI leads to a secondary injury, worsening the effects of the original brain injury. Serotonin is also linked to inflammation in the intestine and inflammatory bowel disease, but its role in the gut-brain axis is not known. We hypothesized that using fluoxetine to block serotonin reuptake would reduce organ inflammation and improve outcomes after TBI., Methods: C57/B6 mice were given a severe TBI using a controlled cortical impact. To measure intestinal permeability, a piece of terminal ileum was resected, the lumen was filled with 4-kDa fluorescein isothiocyanate (FITC)-dextran, and the ends were tied. The intestinal segment was submerged in buffer and fluorescence in the buffer measured over time. To measure lung permeability, 70-kDa FITC-dextran is injected retro-orbitally. Thirty minutes later, the left lung was homogenized and the fluorescence was measured. To measure performance on the rota-rod, mice were placed on a spinning rod, and the time to fall off was measured. Those treated with fluoxetine received a single dose of 5 mg/kg via intraperitoneal injection immediately after injury., Results: Traumatic brain injury was associated with an increase in intestinal permeability to FITC-dextran, increased lung vascular permeability, and worse performance on the rota-rod. Fluoxetine significantly reduced lung and intestinal permeability after TBI and improved performance on the rota-rod after TBI., Conclusion: Use of fluoxetine has the potential to reduce lung injury and improve motor coordination in severe TBI patients. Further study will be needed to elucidate the mechanism behind this effect., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
8. Inhibition of protein glycosylation is a novel pro-angiogenic strategy that acts via activation of stress pathways.
- Author
-
Zhong C, Li P, Argade S, Liu L, Chilla' A, Liang W, Xin H, Eliceiri B, Choudhury B, and Ferrara N
- Subjects
- Animals, Cattle, Cell Proliferation drug effects, Cells, Cultured, Disease Models, Animal, Endoplasmic Reticulum Chaperone BiP, Enzyme Activation drug effects, Female, Glycosylation drug effects, Heat-Shock Proteins metabolism, Hexosamines pharmacology, Hindlimb pathology, Human Umbilical Vein Endothelial Cells drug effects, Human Umbilical Vein Endothelial Cells metabolism, Humans, Ischemia pathology, MAP Kinase Signaling System drug effects, Mice, Inbred C57BL, Microvessels metabolism, Regional Blood Flow drug effects, Signal Transduction drug effects, Skin pathology, Transcription Factor CHOP metabolism, Unfolded Protein Response drug effects, Vascular Endothelial Growth Factor A pharmacology, Vascular Endothelial Growth Factor Receptor-2 metabolism, Wound Healing drug effects, Neovascularization, Physiologic drug effects, Proteins metabolism, Stress, Physiological drug effects
- Abstract
Endothelial cell (EC) metabolism is thought to be one of the driving forces for angiogenesis. Here we report the identification of the hexosamine D-mannosamine (ManN) as an EC mitogen and survival factor for bovine and human microvascular EC, with an additivity with VEGF. ManN inhibits glycosylation in ECs and induces significant changes in N-glycan and O-glycan profiles. We further demonstrate that ManN and two N-glycosylation inhibitors stimulate EC proliferation via both JNK activation and the unfolded protein response caused by ER stress. ManN results in enhanced angiogenesis in a mouse skin injury model. ManN also promotes angiogenesis in a mouse hindlimb ischemia model, with accelerated limb blood flow recovery compared to controls. In addition, intraocular injection of ManN induces retinal neovascularization. Therefore, activation of stress pathways following inhibition of protein glycosylation can promote EC proliferation and angiogenesis and may represent a therapeutic strategy for treatment of ischemic disorders.
- Published
- 2020
- Full Text
- View/download PDF
9. Mast Cell Degranulation and Fibroblast Activation in the Morphine-induced Spinal Mass: Role of Mas-related G Protein-coupled Receptor Signaling.
- Author
-
Yaksh TL, Eddinger KA, Kokubu S, Wang Z, DiNardo A, Ramachandran R, Zhu Y, He Y, Weren F, Quang D, Malkmus SA, Lansu K, Kroeze WK, Eliceiri B, Steinauer JJ, Schiller PW, Gmeiner P, Page LM, and Hildebrand KR
- Subjects
- Analgesics, Opioid administration & dosage, Analgesics, Opioid pharmacology, Animals, Guinea Pigs, Humans, Infusions, Spinal, Male, Models, Animal, Morphine administration & dosage, Signal Transduction physiology, Cell Degranulation drug effects, Fibroblasts drug effects, Mast Cells drug effects, Morphine pharmacology, Receptors, G-Protein-Coupled physiology, Spine drug effects
- Abstract
Background: As the meningeally derived, fibroblast-rich, mass-produced by intrathecal morphine infusion is not produced by all opiates, but reduced by mast cell stabilizers, the authors hypothesized a role for meningeal mast cell/fibroblast activation. Using the guinea pig, the authors asked: (1) Are intrathecal morphine masses blocked by opiate antagonism?; (2) Do opioid agonists not producing mast cell degranulation or fibroblast activation produce masses?; and (3) Do masses covary with Mas-related G protein-coupled receptor signaling thought to mediate mast cell degranulation?, Methods: In adult male guinea pigs (N = 66), lumbar intrathecal catheters connected to osmotic minipumps (14 days; 0.5 µl/h) were placed to deliver saline or equianalgesic concentrations of morphine sulfate (33 nmol/h), 2',6'-dimethyl tyrosine-(Tyr-D-Arg-Phe-Lys-NH2) (abbreviated as DMT-DALDA; 10 pmol/h; μ agonist) or PZM21 (27 nmol/h; biased μ agonist). A second pump delivered subcutaneous naltrexone (25 µg/h) in some animals. After 14 to 16 days, animals were anesthetized and perfusion-fixed. Drug effects on degranulation of human cultured mast cells, mouse embryonic fibroblast activation/migration/collagen formation, and Mas-related G protein-coupled receptor activation (PRESTO-Tango assays) were determined., Results: Intrathecal infusion of morphine, DMT-DALDA or PZM21, but not saline, comparably increased thermal thresholds for 7 days. Spinal masses proximal to catheter tip, composed of fibroblast/collagen type I (median: interquartile range, 0 to 4 scale), were produced by morphine (2.3: 2.0 to 3.5) and morphine plus naltrexone (2.5: 1.4 to 3.1), but not vehicle (1.2: 1.1 to 1.5), DMT-DALDA (1.0: 0.6 to 1.3), or PZM21 (0.5: 0.4 to 0.8). Morphine in a naloxone-insensitive fashion, but not PZM21 or DMT-DALDA, resulted in mast cell degranulation and fibroblast proliferation/collagen formation. Morphine-induced fibroblast proliferation, as mast cell degranulation, is blocked by cromolyn. Mas-related G protein-coupled receptor activation was produced by morphine and TAN67 (∂-opioid agonist), but not by PZM21, TRV130 (mu biased ligand), or DMT-DALDA., Conclusions: Opiates that activate Mas-related G protein-coupled receptor will degranulate mast cells, activate fibroblasts, and result in intrathecal mass formation. Results suggest a mechanistically rational path forward to safer intrathecal opioid therapeutics.
- Published
- 2019
- Full Text
- View/download PDF
10. Exosomes, not protein or lipids, in mesenteric lymph activate inflammation: Unlocking the mystery of post-shock multiple organ failure.
- Author
-
Kojima M, Gimenes-Junior JA, Langness S, Morishita K, Lavoie-Gagne O, Eliceiri B, Costantini TW, and Coimbra R
- Subjects
- Animals, Cells, Cultured, Disease Models, Animal, Flow Cytometry, Immunoblotting, Male, Microscopy, Electron, Transmission, Multiple Organ Failure metabolism, NF-kappa B metabolism, Rats, Rats, Sprague-Dawley, Shock, Hemorrhagic metabolism, Tumor Necrosis Factor-alpha metabolism, Wounds and Injuries metabolism, Exosomes physiology, Lymph cytology, Mesentery metabolism, Multiple Organ Failure physiopathology, Shock, Hemorrhagic physiopathology, Wounds and Injuries physiopathology
- Abstract
Background: Previous studies have shown that mesenteric lymph (ML) has a crucial role in driving the systemic inflammatory response after trauma/hemorrhagic shock (T/HS). The specific mediators in the ML that contribute to its biological activity remain unclear despite decades of study. Exosomes are extracellular vesicles that are shed into body fluids such as serum and urine that can mediate intercellular communication. We hypothesized that exosomes are present in the ML after trauma/shock and are responsible for the biological activity of ML., Methods: Male rats underwent cannulation of the vessels and mesenteric lymph duct. T/HS was induced by laparotomy and 60 minutes of HS (mean arterial pressure, 35 mmHg), followed by resuscitation. The ML was collected during three distinct time periods (pre-shock, shock, and resuscitation phase) and subsequently separated into exosome and supernatant fractions. Exosomes were characterized by electron microscope, nanoparticle tracking analysis, and immunoblotting. The biological activity of exosomes and supernatant of ML were characterized using a monocyte NF-κB reporter assay and by measuring macrophage intracellular TNF-α production., Results: Exosomes were identified in ML by size and expression of the exosome markers CD63 and HSP70. The number of exosomes present in the ML was 2-fold increased during shock and 4-fold decreased in resuscitation phase compared to pre-shock. However, biological activity of exosomes isolated during the resuscitation phase was markedly increased and caused an 8-fold increase in monocyte NF-κB activation compared to supernatant. Macrophage TNF-α production was also increased after exposure to exosomes harvested in the resuscitation phase. The ML supernatant fraction had no effect on TNF-α production during any phase., Conclusions: Our findings show that exosomes, and not the liquid fraction of ML, are the major component triggering inflammatory responses in monocytes and macrophages after experimental T/HS.
- Published
- 2017
- Full Text
- View/download PDF
11. A pharmacologic approach to vagal nerve stimulation prevents mesenteric lymph toxicity after hemorrhagic shock.
- Author
-
Morishita K, Costantini TW, Ueno A, Bansal V, Eliceiri B, and Coimbra R
- Subjects
- Animals, Disease Models, Animal, Flow Cytometry, Hemodynamics drug effects, Lung Injury etiology, Lung Injury physiopathology, Lymphatic Vessels metabolism, Male, Mesentery metabolism, Rats, Rats, Sprague-Dawley, Shock, Hemorrhagic physiopathology, Vagus Nerve physiopathology, Hydrazones pharmacology, Lung Injury prevention & control, Shock, Hemorrhagic complications, Systemic Inflammatory Response Syndrome prevention & control, Vagus Nerve drug effects, Vagus Nerve Stimulation methods
- Abstract
Background: Electrical stimulation of the vagus nerve (VN) prevents gut and lung inflammation and mesenteric lymph (ML) toxicity in animal models of injury. We have previously shown that treatment with CPSI-121, a guanylhydrazone-derived compound, prevents gut barrier failure after burn injury. While the structure of CPSI-121 predicts that it will activate parasympathetic signaling, its ability to stimulate the VN is unknown. The aims of this study were to (1) measure the ability of CPSI-121 to induce VN activity, (2) determine whether CPSI-121 causes significant hemodynamic effects, and (3) further define the potential for CPSI-121 to limit the systemic inflammatory response to injury., Methods: Male Sprague-Dawley rats were given 1-mg/kg CPSI-121 intravenously while blood pressure, heart rate, and efferent VN electrical activity were recorded. Rats were also assigned to sham or trauma/hemorrhagic shock (T/HS). T/HS was induced by laparotomy and 60 minutes of HS (mean arterial pressure, 35 mm Hg) followed by fluid resuscitation. A separate cohort of animals received CPSI-121 after the HS phase. Gut and lung tissues were harvested for histologic analysis. Lung wet-dry ratios were also evaluated. The ability of ML to prime neutrophils was assessed by measuring in vitro oxidative burst using flow cytometry., Results: Blood pressure was not altered after treatment with CPSI-121, while heart rate decreased only slightly. Recording of efferent VN electrical activity revealed an increase in discharge rate after administration of CPSI-121. T/HS caused gut and lung injury, which were prevented in animals treated with CPSI-121 (p < 0.05). Treatment with CPSI-121 following T/HS attenuated neutrophil priming after exposure to ML (p < 0.05)., Conclusion: CPSI-121 causes efferent VN output and limits shock-induced gut and lung injury as well as ML toxicity. CPSI-121 is a candidate pharmacologic approach to VN stimulation aimed at limiting the inflammatory response in patients following T/HS.
- Published
- 2015
- Full Text
- View/download PDF
12. Ghrelin decreases motor deficits after traumatic brain injury.
- Author
-
Lopez NE, Gaston L, Lopez KR, Hageny AM, Putnam J, Eliceiri B, Coimbra R, and Bansal V
- Subjects
- Animals, Apoptosis drug effects, Blood-Brain Barrier drug effects, Blood-Brain Barrier pathology, Brain Injuries complications, Cerebral Cortex injuries, Cerebral Cortex pathology, Disease Models, Animal, Male, Mice, Mice, Inbred BALB C, Motor Skills Disorders etiology, Nerve Degeneration drug therapy, Nerve Degeneration pathology, Recovery of Function drug effects, Brain Injuries drug therapy, Brain Injuries pathology, Ghrelin pharmacology, Motor Skills Disorders drug therapy, Motor Skills Disorders pathology
- Abstract
Background: Pharmacologic therapy for traumatic brain injury (TBI) has remained relatively unchanged for decades. Ghrelin, an endogenously produced peptide, has been shown to prevent apoptosis and blood-brain barrier dysfunction after TBI. We hypothesize that ghrelin treatment will prevent neuronal degeneration and improve motor coordination after TBI., Materials and Methods: A weight drop model created severe TBI in three groups of BALB/c mice: Sham, TBI, and TBI + ghrelin (20 μg intraperitoneal ghrelin). Brain tissue was examined by hematoxylin and eosin and Fluoro-Jade B (FJB) staining to evaluate histologic signs of injury, cortical volume loss, and neuronal degeneration. Additionally, motor coordination was assessed., Results: Ghrelin treatment prevented volume loss after TBI (19.4 ± 9.8 mm(3)versus 71.4 ± 31.4 mm(3); P < 0.05). Similarly, although TBI increased FJB-positive neuronal degeneration, ghrelin treatment decreased FJB staining in TBI resulting in immunohistologic patterns similar to sham. Compared with sham, TBI animals had a significant increase in foot faults at d 1, 3, and 7 (2.75 ± 0.42; 2.67 ± 0.94; 3.33 ± 0.69 versus 0.0 ± 0.0; 0.17 ± 0.19; 0.0 ± 0.0; P < 0.001). TBI + ghrelin animals had significantly decreased foot faults compared with TBI at d 1, 3, and 7 (0.42 ± 0.63; 0.5 ± 0.43; 1.33 ± 0.58; P versus TBI <0.001; P versus sham = NS)., Conclusions: Ghrelin treatment prevented post-TBI cortical volume loss and neurodegeneration. Furthermore, ghrelin improved post-TBI motor deficits. The mechanisms of these effects are unclear; however, a combination of the anti-apoptotic and inflammatory modulatory effects of ghrelin may play a role. Further studies delineating the mechanism of these observed effects are warranted., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
13. Vagal nerve stimulation modulates the dendritic cell profile in posthemorrhagic shock mesenteric lymph.
- Author
-
Morishita K, Costantini TW, Eliceiri B, Bansal V, and Coimbra R
- Subjects
- Animals, Antigens, CD physiology, Flow Cytometry, Integrin alpha Chains physiology, Lymph physiology, Male, Mesentery, Rats, Rats, Sprague-Dawley, Vagus Nerve Stimulation, Wounds and Injuries physiopathology, Dendritic Cells physiology, Lymph cytology, Shock, Hemorrhagic physiopathology, Vagus Nerve physiopathology
- Abstract
Background: Previous studies have established that posthemorrhagic shock mesenteric lymph (PHSML) contains proinflammatory mediators, while the cellular basis of PHSML is less well characterized in acute models of injury. CD103 dendritic cells (DCs) have been identified in the mesenteric lymph (ML) in models of chronic intestinal inflammation, suggesting an important role in the gut response to injury. We have previously demonstrated the ability of vagal nerve stimulation (VNS) to prevent gut barrier failure after trauma/hemorrhagic shock (T/HS); however, the ability of VNS to alter ML DCs is unknown. We hypothesized that the CD103 MHC-II DC population would change in PHSML and that VNS would prevent injury-induced changes in this population in PHSML., Methods: Male Sprague-Dawley rats were randomly assigned to trauma/sham shock or T/HS. T/HS was induced by midline laparotomy and 60 minutes of HS (blood pressure, 35 mm Hg), followed by fluid resuscitation. A separate cohort of animals underwent cervical VNS after the HS phase. Gut tissue was harvested at 2 hours after injury for histologic analysis. ML was collected during the pre-HS, HS, and post-HS phase. For flow cytometric analysis, ML cells were subjected to staining with CD103 and MHC-II antibodies, and this cell population was compared in the pre-HS and post-HS phase from the same animal. The CD4Foxp3 cell (T reg) population in the ML node (MLN) was also tested to determine effects of CD103 DC modulation in the ML., Results: VNS reduced histologic gut injury and ML flow seen after injury. The CD103 MHC-II DC population in the PHSML was significantly decreased compared with pre-HS and was associated with decreased T reg expression in the MLN. VNS prevented the injury-induced decrease in the CD103 MHC-II+ DC population in the ML and restored the T reg population in the MLN., Conclusion: These findings suggest that VNS mediates the inflammatory responses in ML DCs and MLN T reg cells by affecting the set point of T/HS responsiveness.
- Published
- 2014
- Full Text
- View/download PDF
14. Vagal nerve stimulation protects cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model.
- Author
-
Lu X, Costantini T, Lopez NE, Wolf PL, Hageny AM, Putnam J, Eliceiri B, and Coimbra R
- Subjects
- Adenosine Triphosphate metabolism, Animals, Apoptosis, Apoptosis Inducing Factor metabolism, Blotting, Western, Burns prevention & control, Cytochromes c metabolism, Cytosol metabolism, Disease Models, Animal, Male, Mice, Mice, Inbred BALB C, Mitochondria, Heart metabolism, Mitochondrial Swelling, Myocardium enzymology, Myocytes, Cardiac enzymology, Myocytes, Cardiac pathology, Phosphatidylinositol 3-Kinases metabolism, Phosphorylation, Proto-Oncogene Proteins c-akt metabolism, Proto-Oncogene Proteins c-bcl-2 metabolism, Signal Transduction, bcl-Associated Death Protein metabolism, Burns pathology, Mitochondria, Heart pathology, Myocardium pathology, Vagus Nerve Stimulation
- Abstract
Mitochondria play a central role in the integration and execution of a wide variety of apoptotic signals. In the present study, we examined the deleterious effects of burn injury on heart tissue. We explored the effects of vagal nerve stimulation (VNS) on cardiac injury in a murine burn injury model, with a focus on the protective effect of VNS on mitochondrial dysfunction in heart tissue. Mice were subjected to a 30% total body surface area, full-thickness steam burn followed by right cervical VNS for 10 min. and compared to burn alone. A separate group of mice were treated with the M3-muscarinic acetylcholine receptor (M3-AchR) antagonist 4-DAMP or phosphatidylinositol 3 Kinase (PI3K) inhibitor LY294002 prior to burn and VNS. Heart tissue samples were collected at 6 and 24 hrs after injury to measure changes in apoptotic signalling pathways. Burn injury caused significant cardiac pathological changes, cardiomyocyte apoptosis, mitochondrial swelling and decrease in myocardial ATP content at 6 and 24 hrs after injury. These changes were significantly attenuated by VNS. VNS inhibited release of pro-apoptotic protein cytochrome C and apoptosis-inducing factor from mitochondria to cytosol by increasing the expression of Bcl-2, and the phosphorylation level of Bad (pBad(136)) and Akt (pAkt(308)). These protective changes were blocked by 4-DAMP or LY294002. We demonstrated that VNS protected against burn injury-induced cardiac injury by attenuating mitochondria dysfunction, likely through the M3-AchR and the PI3K/Akt signalling pathways., (© 2013 The Authors. Published by Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
15. Uncovering the neuroenteric-pulmonary axis: vagal nerve stimulation prevents acute lung injury following hemorrhagic shock.
- Author
-
Reys LG, Ortiz-Pomales YT, Lopez N, Cheadle G, de Oliveira PG, Eliceiri B, Bansal V, Costantini TW, and Coimbra R
- Subjects
- Acute Lung Injury pathology, Animals, Intercellular Adhesion Molecule-1 analysis, Intestinal Mucosa physiopathology, Male, Mice, Mice, Inbred BALB C, NF-kappa B analysis, Permeability, Peroxidase analysis, Tight Junctions pathology, Acute Lung Injury prevention & control, Intestinal Mucosa pathology, Lung pathology, Shock, Hemorrhagic complications, Vagus Nerve Stimulation methods
- Abstract
Aims: Trauma/hemorrhagic shock (T/HS) induced gut injury is known to initiate a systemic inflammatory response which can lead to secondary lung injury. We have shown that vagal nerve stimulation (VNS) protects intestinal epithelial integrity after a severe burn insult. We hypothesize that VNS will protect the lung from injury following T/HS by preventing intestinal barrier failure., Main Methods: Male Balb/c mice were subjected to a T/HS model with and without cervical VNS. Intestinal injury was evaluated by measuring changes in gut barrier function and tight junction protein localization. Lung injury was evaluated using histology and markers of lung inflammation. Using NF-kB-luciferase (NF-kB-luc) transgenic mice, NF-kb-DNA binding was measured by photon emission analysis at 4 after injury., Key Findings: T/HS is associated gut injury characterized by histologic injury, increased epithelial permeability, and altered localization of gut tight junction proteins. Cervical VNS prevented the T/HS-induced changes in gut barrier integrity. Gut injury after T/HS was associated with acute lung injury at 24 h characterized by histologic injury, increased number of MPO positive stained cells and MPO enzymatic activity, and increased ICAM-1 expression in lung endothelium. VNS decreased T/HS-induced lung injury with a marked decrease in lung inflammation compared to T/HS alone. Lungs harvested from NF-kB-luc mice at 4h post VNS+T/HS demonstrated decreased DNA binding of NF-kB compared to T/HS alone as measured by changes in bioluminescence., Significance: VNS is effective in protecting against acute lung injury caused by hemorrhagic shock through its ability to prevent gut barrier dysfunction., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
16. Early ghrelin treatment attenuates disruption of the blood brain barrier and apoptosis after traumatic brain injury through a UCP-2 mechanism.
- Author
-
Lopez NE, Gaston L, Lopez KR, Coimbra RC, Hageny A, Putnam J, Eliceiri B, Coimbra R, and Bansal V
- Subjects
- Animals, Apoptosis physiology, Blood-Brain Barrier physiology, Brain Injuries metabolism, Brain Injuries pathology, Capillary Permeability drug effects, Capillary Permeability physiology, Caspase 3 metabolism, Disease Models, Animal, Ghrelin metabolism, Male, Mice, Mice, Inbred BALB C, Mitochondria drug effects, Mitochondria metabolism, Neuroprotective Agents metabolism, Neuroprotective Agents pharmacology, Uncoupling Protein 2, Apoptosis drug effects, Blood-Brain Barrier drug effects, Brain Injuries drug therapy, Ghrelin pharmacology, Ion Channels metabolism, Mitochondrial Proteins metabolism
- Abstract
Ghrelin has been shown to be anti-inflammatory and neuroprotective in models of neurologic injury. We hypothesize that treatment with ghrelin will attenuate breakdown of the blood brain barrier (BBB) and apoptosis 24h following traumatic brain injury (TBI). We believe this protection is at least in part mediated by up-regulation of UCP-2, thereby stabilizing mitochondria and preventing up-regulation of caspase-3. A weight drop model was used to create severe TBI. Balb/c mice were divided into 3 groups. Sham: no TBI or ghrelin treatment; TBI: TBI only; TBI/ghrelin: 20μg (IP) ghrelin at the time of TBI. BBB permeability to 70kDa FITC-Dextran was measured 24h following injury and quantified in arbitrary integrated fluorescence (afu). Brain tissue was subjected to TUNEL staining and TUNEL positive cells were quantified. Immunohistochemistry was performed on injured tissue to reveal patterns of caspase-3 and UCP-2 expression. TBI increased cerebral vascular permeability by three-fold compared to sham. Ghrelin treatment restored vascular permeability to the level of shams. TUNEL staining showed that ghrelin mitigated the significant increase in apoptosis that follows TBI. TBI increased both caspase-3 compared to sham. Treatment with ghrelin significantly increased UCP-2 compared to TBI alone and this increase in UCP-2 expression was associated with a decrease in expression of caspase-3. Early ghrelin treatment prevents TBI induced BBB disruption and TBI mediated apoptosis 24h following injury. These results demonstrate the neuroprotective potential of ghrelin as a therapy in TBI., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
17. Vagal nerve stimulation decreases blood-brain barrier disruption after traumatic brain injury.
- Author
-
Lopez NE, Krzyzaniak MJ, Costantini TW, Putnam J, Hageny AM, Eliceiri B, Coimbra R, and Bansal V
- Subjects
- Analysis of Variance, Animals, Aquaporin 4 genetics, Blood-Brain Barrier metabolism, Brain Injuries metabolism, Disease Models, Animal, Fluorescein-5-isothiocyanate pharmacokinetics, Fluorescence, Immunohistochemistry, Male, Mice, Mice, Inbred BALB C, Microscopy, Confocal, Random Allocation, Reference Values, Treatment Outcome, Up-Regulation, Aquaporin 4 metabolism, Blood-Brain Barrier physiopathology, Brain Injuries pathology, Brain Injuries therapy, Dextrans pharmacokinetics, Fluorescein-5-isothiocyanate analogs & derivatives, Vagus Nerve Stimulation methods
- Abstract
Background: Traumatic brain injury (TBI) may alter sympathetic tone causing autonomic abnormalities and organ dysfunction. Vagal nerve stimulation (VNS) has been shown to decrease inflammation and distant organ injury after TBI. It is unknown whether VNS may reduce blood-brain barrier (BBB) dysfunction after TBI.We hypothesize that VNS prevents TBI-induced breakdown of the BBB, subsequent brain edema, and neuronal injury., Methods: A weight-drop model was used to create severe TBI in balb/c mice. Animals were divided into three groups: TBI-TBI only; TBI or VNS--animals that were treated with 10 minutes of VNS immediately before TBI; and sham--animals with opening of the skull but no TBI and VNS treatment. Brain vascular permeability to injected (Mr 70,000) FITC-dextran was measured by radiated fluorescence 6 hours after injury. Injured tissue sections were stained for perivascular aquaporin 4 (AQP-4), an important protein causing BBB--mediated brain edema. Fluorescence was quantified under laser scanning by confocal microscopy., Results: Six hours after TBI, cerebral vascular permeability was increased fourfold compared with sham (mean [SD], 6.6(E+08) [5.5(E+07)] arbitrary fluorescence units [afu] vs. 1.5(E+08) [2.9(E+07)] afu; p G 0.001). VNS prevented the increase in permeability when compared with TBI alone (mean [SD], 3.5 (E+08) [8.3(E+07)] afu vs. 6.6(E+08) [5.5(E+07)] afu; p G 0.05). Perivascular expression of AQP-4 was increased twofold in TBI animals compared with sham (mean [SD], 0.96 [0.12] afu vs. 1.79 [0.37] afu; p G 0.05). Similarly, VNS decreased post-TBI expression of AQP-4 to levels similar to sham (mean [SD], 1.15 [0.12] afu; p G 0.05)., Conclusion: VNS attenuates cerebral vascular permeability and decreases the up-regulation of AQP-4 after TBI. Future studies are needed to assess the mechanisms by which VNS maintains the BBB., (Copyright © 2012 by Lippincott Williams & Wilkins.)
- Published
- 2012
- Full Text
- View/download PDF
18. Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4.
- Author
-
Dang X, Podvin S, Coimbra R, Eliceiri B, and Baird A
- Subjects
- Cell Line, Tumor, Cell Membrane drug effects, Cell Membrane metabolism, Culture Media pharmacology, HEK293 Cells, Hormones chemistry, Humans, Models, Molecular, Molecular Weight, Mutagenesis drug effects, Mutagenesis genetics, Neoplasm Proteins chemistry, Organ Specificity drug effects, Protein Precursors chemistry, Protein Transport, Structure-Activity Relationship, Tetradecanoylphorbol Acetate pharmacology, Tumor Suppressor Proteins chemistry, Hormones metabolism, Neoplasm Proteins metabolism, Protein Precursors metabolism, Protein Processing, Post-Translational drug effects, Tumor Suppressor Proteins metabolism
- Abstract
The human open reading frame C2orf40 encodes esophageal cancer-related gene-4 (Ecrg4), a newly recognized neuropeptide-like precursor protein whose gene expression by cells in vitro, over-expression in mice in vivo, and knock-down in zebrafish affects cell proliferation, migration and senescence, progenitor cell survival and differentiation, and inflammatory function. Unlike traditionally secreted neuropeptide precursors, however, we find that Ecrg4 localizes to the epithelial cell surface and remains tethered after secretion. Here, we used cell surface biotinylation to establish that 14-kDa Ecrg4 localizes to the cell surface of prostate (PC3) or kidney (HEK) epithelial cells after transfection. Accordingly, this Ecrg4 is resistant to washing cells with neutral, high salt (2 M NaCl), acidic (50 mM glycine, pH 2.8), or basic (100 mM Na(2)CO(3), pH 11) buffers. Mutagenesis of Ecrg4 established that cell tethering was mediated by an NH(2)-terminus hydrophobic leader sequence that enabled both trafficking to the surface and tethering. Immunoblotting analyses, however, showed that different cells process Ecrg4 differently. Whereas PC3 cells release cell surface Ecrg4 to generate soluble Ecrg4 peptides of 6-14 kDa, HEK cells do neither, and the 14-kDa precursor resembles a sentinel attached to the cell surface. Because a phorbol ester treatment of PC3 cells stimulated Ecrg4 release from, and processing at, the cell surface, these data are consistent with a multifunctional role for Ecrg4 that is dependent on its cell of origin and the molecular form produced.
- Published
- 2012
- Full Text
- View/download PDF
19. CPSI-121 pharmacologically prevents intestinal barrier dysfunction after cutaneous burn through a vagus nerve-dependent mechanism.
- Author
-
Krzyzaniak M, Ortiz-Pomales Y, Lopez N, Reys LG, Cheadle G, Wolf P, Eliceiri B, Bansal V, Baird A, and Coimbra R
- Subjects
- Analysis of Variance, Animals, Immunoblotting, Male, Membrane Proteins metabolism, Mice, Mice, Inbred BALB C, Microscopy, Confocal, Occludin, Permeability drug effects, Statistics, Nonparametric, Vagus Nerve, Burns metabolism, Burns physiopathology, Hydrazones pharmacology, Intestinal Mucosa metabolism, Intestinal Mucosa physiopathology, Vagus Nerve Stimulation
- Abstract
Background: We have recently demonstrated the protective effects of electrical stimulation of the vagus nerve in prevention of gut injury after severe burn. Here we evaluate the potential for a pharmacologic agonist of the vagus nerve as an approach to regulate outcomes in preclinical models. We tested a new generation of guanylhydrazone-derived compounds, CPSI-121; a compound that may activate the parasympathetic nervous system through poorly understood mechanisms to determine whether we could prevent intestinal mucosal barrier breakdown., Methods: Male balb/c mice were subjected to a full-thickness, 30% total body surface area steam burn, and the efficacy of CPSI-121 was tested against vagus nerve stimulation (VNS) postburn at 4 hours. Surgical vagotomy was used to disrupt the neuroenteric axis and gut injury prevention was assessed. Gut barrier dysfunction was quantified by permeability to 4-kDa fluorescein isothiocyanate-dextran. Gut injury was assessed by histologic evaluation. Tight junction protein expression (ZO-1 and occludin) was characterized by immunofluorescence and immunoblot., Results: VNS and CPSI-121 administration significantly reduced the permeability to 4-kDa fluorescein isothiocyanate-dextran and maintained normal histology compared with burn. However, abdominal vagotomy eliminated the protective effects of both VNS and CPSI-121. ZO-1 and occludin expression was similar to sham in VNS and CPSI-121-treated burn animals, but significantly altered in burn-vagotomized animals. Splenectomy did not alter the effect of CPSI-121., Conclusion: Similar to direct electrical VNS, CPSI-121 effectively protects the intestinal mucosal barrier from breakdown after severe burn. We suggest that this could represent a noninvasive therapy to prevent end-organ dysfunction after trauma that would be administered during resuscitation.
- Published
- 2012
- Full Text
- View/download PDF
20. Vagal stimulation modulates inflammation through a ghrelin mediated mechanism in traumatic brain injury.
- Author
-
Bansal V, Ryu SY, Lopez N, Allexan S, Krzyzaniak M, Eliceiri B, Baird A, and Coimbra R
- Subjects
- Acetylcholine metabolism, Animals, Disease Models, Animal, Ghrelin blood, Inflammation metabolism, Male, Mice, Mice, Inbred BALB C, Receptors, Ghrelin metabolism, Tumor Necrosis Factor-alpha blood, Brain Injuries metabolism, Ghrelin metabolism, Inflammation therapy, Vagus Nerve Stimulation
- Abstract
Traumatic brain injury (TBI) releases a cascade of inflammatory cytokines. Vagal nerve stimulation (VNS) and ghrelin have known anti-inflammatory effects; furthermore, ghrelin release is stimulated by acetylcholine. We hypothesized VNS decreases post-TBI inflammation through a ghrelin-mediated mechanism. TBI was created in five groups of mice: sham, TBI, TBI/ghrelin, TBI/VNS, and TBI/VNS/ghrelin receptor antagonist (GRa). Serum and tissue ghrelin, and serum TNF-α were measured. Ghrelin increased following VNS 2 h post-TBI compared to sham or TBI. At 6 h, TBI and TBI/VNS/GRa had increased TNF-α compared to sham while TBI/VNS and TBI/ghrelin had TNF-α level comparable to sham. The highest ghrelin was measured in stomach where TBI decreased ghrelin in contrast to an increase by VNS. In conclusion, VNS increased serum ghrelin and decreased TNF-α following TBI. This was abrogated with GRa. Our data suggests that ghrelin plays an important role in the anti-inflammatory effects of VNS following TBI.
- Published
- 2012
- Full Text
- View/download PDF
21. Ghrelin prevents disruption of the blood-brain barrier after traumatic brain injury.
- Author
-
Lopez NE, Krzyzaniak MJ, Blow C, Putnam J, Ortiz-Pomales Y, Hageny AM, Eliceiri B, Coimbra R, and Bansal V
- Subjects
- Animals, Blood-Brain Barrier pathology, Brain Injuries drug therapy, Brain Injuries pathology, Capillary Permeability drug effects, Capillary Permeability physiology, Disease Models, Animal, Ghrelin therapeutic use, Male, Mice, Mice, Inbred BALB C, Blood-Brain Barrier drug effects, Blood-Brain Barrier physiopathology, Brain Injuries physiopathology, Ghrelin physiology
- Abstract
Significant effort has been focused on reducing neuronal damage from post-traumatic brain injury (TBI) inflammation and blood-brain barrier (BBB)-mediated edema. The orexigenic hormone ghrelin decreases inflammation in sepsis models, and has recently been shown to be neuroprotective following subarachnoid hemorrhage. We hypothesized that ghrelin modulates cerebral vascular permeability and mediates BBB breakdown following TBI. Using a weight-drop model, TBI was created in three groups of mice: sham, TBI, and TBI/ghrelin. The BBB was investigated by examining its permeability to FITC-dextran and through quantification of perivascualar aquaporin-4 (AQP-4). Finally, we immunoblotted for serum S100B as a marker of brain injury. Compared to sham, TBI caused significant histologic neuronal degeneration, increases in vascular permeability, perivascular expression of AQP-4, and serum levels of S100B. Treatment with ghrelin mitigated these effects; after TBI, ghrelin-treated mice had vascular permeability and perivascular AQP-4 and S100B levels that were similar to sham. Our data suggest that ghrelin prevents BBB disruption after TBI. This is evident by a decrease in vascular permeability that is linked to a decrease in AQP-4. This decrease in vascular permeability may diminish post-TBI brain tissue damage was evident by decreased S100B.
- Published
- 2012
- Full Text
- View/download PDF
22. Efferent vagal nerve stimulation attenuates acute lung injury following burn: The importance of the gut-lung axis.
- Author
-
Krzyzaniak MJ, Peterson CY, Cheadle G, Loomis W, Wolf P, Kennedy V, Putnam JG, Bansal V, Eliceiri B, Baird A, and Coimbra R
- Subjects
- Acute Lung Injury etiology, Animals, Biopsy, Needle, Burns diagnosis, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Immunoblotting, Immunohistochemistry, Intercellular Adhesion Molecule-1 metabolism, Intestinal Mucosa pathology, Male, Mice, Mice, Inbred BALB C, Peroxidase metabolism, Random Allocation, Reference Values, Treatment Outcome, Vagotomy methods, Acute Lung Injury pathology, Acute Lung Injury prevention & control, Burns complications, Gastrointestinal Tract pathology, Vagus Nerve Stimulation methods
- Abstract
Background: The purpose of this study was to assess acute lung injury when protection to the gut mucosal barrier offered by vagus nerve stimulation is eliminated by an abdominal vagotomy., Methods: Male balb/c mice were subjected to 30% total body surface area steam burn with and without electrical stimulation to the right cervical vagus nerve. A cohort of animals were subjected to abdominal vagotomy. Lung histology, myeloperoxidase and ICAM-1 immune staining, myeloperoxidase enzymatic assay, and tissue KC levels were analyzed 24 hours after burn. Additionally, lung IkB-α, NF-kB immunoblots, and NF-kB-DNA binding measured by photon emission analysis using NF-kB-luc transgenic mice were performed., Results: Six hours post burn, phosphorylation of both NF-kB p65 and IkB-α were observed. Increased photon emission signal was seen in the lungs of NF-kB-luc transgenic animals. Vagal nerve stimulation blunted NF-kB activation similar to sham animals whereas abdominal vagotomy eliminated the anti-inflammatory effect. After burn, MPO positive cells and ICAM-1 expression in the lung endothelium was increased, and lung histology demonstrated significant injury at 24 hours. Vagal nerve stimulation markedly decreased neutrophil infiltration as demonstrated by MPO immune staining and enzyme activity. Vagal stimulation also markedly attenuated acute lung injury at 24 hours. The protective effects of vagal nerve stimulation were reversed by performing an abdominal vagotomy., Conclusion: Vagal nerve stimulation is an effective strategy to protect against acute lung injury following burn. Moreover, the protective effects of vagal nerve stimulation in the prevention of acute lung injury are eliminated by performing an abdominal vagotomy. These results establish the importance of the gut-lung axis after burn in the genesis of acute lung injury., (Copyright © 2011 Mosby, Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
23. Burn-induced acute lung injury requires a functional Toll-like receptor 4.
- Author
-
Krzyzaniak M, Cheadle G, Peterson C, Loomis W, Putnam J, Wolf P, Baird A, Eliceiri B, Bansal V, and Coimbra R
- Subjects
- Animals, Blotting, Western, Enzyme-Linked Immunosorbent Assay, High Mobility Group Proteins metabolism, I-kappa B Proteins metabolism, Intercellular Adhesion Molecule-1, Interleukin-8 metabolism, Male, Mice, Mice, Inbred C57BL, NF-KappaB Inhibitor alpha, Peroxidase metabolism, Transcription Factor RelA metabolism, Acute Lung Injury metabolism, Burns metabolism, Burns physiopathology, Toll-Like Receptor 4 metabolism
- Abstract
The role of the Toll-like receptor 4 (TLR4), a component of the innate immune system, in the development of burn-induced acute lung injury (ALI) has not been completely defined. Recent data suggested that an intact TLR4 plays a major role in the development of organ injury in sterile inflammation. We hypothesized that burn-induced ALI is a TLR4-dependent process. Male C57BL/6J (TLR4 wild-type [WT]) and C57BL/10ScN (TLR4 knockout [KO]) mice were subjected to a 30% total body surface area steam burn. Animals were killed at 6 and 24 h after the insult. Lung specimens were harvested for histological examination after hematoxylin-eosin staining. In addition, lung myeloperoxidase (MPO) and intercellular adhesion molecule 1 immunostaining was performed. Lung MPO was measured by an enzymatic assay. Total lung keratinocyte-derived chemoattractant (IL-8) content was measured by enzyme-linked immunosorbent assay. Western blot was performed to quantify phosphorylated IκBα, phosphorylated nuclear factor κB p65 (NF-κBp65), and high mobility group box 1 expression. Acute lung injury, characterized by thickening of the alveolar-capillary membrane, hyaline membrane formation, intraalveolar hemorrhage, and neutrophil infiltration, was seen in WT but not KO animals at 24 h. Myeloperoxidase and intercellular adhesion molecule 1 immunostaining of KO animals was also similar to sham but elevated in WT animals. In addition, a reduction in MPO enzymatic activity was observed in KO mice as well as a reduction in IL-8 levels compared with their WT counterparts. Burn-induced ALI develops within 24 h after the initial thermal insult in our model. Toll-like receptor 4 KO animals were clearly protected and had a much less severe lung injury. Our data suggest that burn-induced ALI is a TLR4-dependent process.
- Published
- 2011
- Full Text
- View/download PDF
24. Postinjury vagal nerve stimulation protects against intestinal epithelial barrier breakdown.
- Author
-
Krzyzaniak M, Peterson C, Loomis W, Hageny AM, Wolf P, Reys L, Putnam J, Eliceiri B, Baird A, Bansal V, and Coimbra R
- Subjects
- Animals, Burns physiopathology, Burns therapy, Disease Models, Animal, Intestinal Mucosa pathology, Male, Mice, Mice, Inbred BALB C, Microscopy, Confocal, Permeability, Burns metabolism, Intestinal Mucosa metabolism, Membrane Proteins metabolism, Vagus Nerve Stimulation methods
- Abstract
Background: Vagal nerve stimulation (VNS) can have a marked anti-inflammatory effect. We have previously shown that preinjury VNS prevented intestinal barrier breakdown and preserved epithelial tight junction protein expression. However, a pretreatment model has little clinical relevance for the care of the trauma patient. Therefore, we postulated that VNS conducted postinjury would also have a similar protective effect on maintaining gut epithelial barrier integrity., Methods: Male balb/c mice were subjected to a 30% total body surface area, full-thickness steam burn followed by right cervical VNS at 15, 30, 60, 90, 120, and 150 minutes postinjury. Intestinal barrier dysfunction was quantified by permeability to 4 kDa fluorescein isothiocyanate-Dextran, histologic evaluation, gut tumor necrosis factor-alpha (TNF-α) enzyme-linked immunosorbent assay, and expression of tight junction proteins (myosin light chain kinase, occludin, and ZO-1) using immunoblot and immunoflourescence., Results: Histologic examination documented intestinal villi appearance similar to sham if cervical VNS was performed within 90 minutes of burn insult. VNS done after injury decreased intestinal permeability to fluorescein isothiocyanate-Dextran when VNS was ≤90 minutes after injury. Burn injury caused a marked increase in intestinal TNF-α levels. VNS-treated animals had TNF-α levels similar to sham when VNS was performed within 90 minutes of injury. Tight junction protein expression was maintained at near sham values if VNS was performed within 90 minutes of burn, whereas expression was significantly altered in burn., Conclusion: Postinjury VNS prevents gut epithelial breakdown when performed within 90 minutes of thermal injury. This could represent a therapeutic window and clinically relevant strategy to prevent systemic inflammatory response distant organ injury after trauma.
- Published
- 2011
- Full Text
- View/download PDF
25. The hormone ghrelin prevents traumatic brain injury induced intestinal dysfunction.
- Author
-
Bansal V, Ryu SY, Blow C, Costantini T, Loomis W, Eliceiri B, Baird A, Wolf P, and Coimbra R
- Subjects
- Animals, Blotting, Western, Brain Injuries metabolism, Brain Injuries pathology, Ileum drug effects, Ileum pathology, Intestinal Diseases etiology, Intestinal Diseases metabolism, Intestinal Diseases pathology, Intestinal Mucosa drug effects, Intestinal Mucosa pathology, Mice, Mice, Inbred BALB C, Permeability drug effects, Tight Junctions drug effects, Tight Junctions pathology, Tumor Necrosis Factor-alpha metabolism, Brain Injuries complications, Ghrelin therapeutic use, Ileum metabolism, Intestinal Diseases drug therapy, Intestinal Mucosa metabolism, Tight Junctions metabolism
- Abstract
Intestinal barrier breakdown following traumatic brain injury (TBI) is characterized by increased intestinal permeability, leading to bacterial translocation, and inflammation. The hormone ghrelin may prevent intestinal injury and have anti-inflammatory properties. We hypothesized that exogenous ghrelin prevents intestinal injury following TBI. A weight-drop model created severe TBI in three groups of anesthetized Balb/c mice. Group TBI: animals underwent TBI only; Group TBI/ghrelin: animals were given 10 μg of ghrelin intraperitoneally prior and 1 h following TBI; Group sham: no TBI or ghrelin injection. Intestinal permeability was measured 6 h following TBI by detecting serum levels of FITC-Dextran after injection into the intact ileum. The terminal ileum was harvested for histology, expression of the tight junction protein MLCK and inflammatory cytokine TNF-α. Permeability increased in the TBI group compared to the sham group (109.7 ± 21.8 μg/mL vs. 32.2 ± 10.1 μg/mL; p < 0.002). Ghrelin prevented TBI-induced permeability (28.3 ± 4.2 μg/mL vs. 109.7 ± 21.8 μg/mL; p < 0.001). The intestines of the TBI group showed blunting and necrosis of villi compared to the sham group, while ghrelin injection preserved intestinal architecture. Intestinal MLCK increased 73% compared to the sham group (p < 0.03). Ghrelin prevented TBI-induced MLCK expression to sham levels. Intestinal TNF-α increased following TBI compared to the sham group (46.2 ± 7.1 pg/mL vs. 24.4 ± 2.2 pg/mL p < 0.001). Ghrelin reduced TNF-α to sham levels (29.2 ± 5.0 pg/mL; p = NS). We therefore conclude that ghrelin prevents TBI-induced injury, as determined by intestinal permeability, histology, and intestinal levels of TNF-α. The mechanism for ghrelin mediating intestinal protection is likely multifactorial, and further studies are needed to delineate these possibilities.
- Published
- 2010
- Full Text
- View/download PDF
26. Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid.
- Author
-
Gonzalez AM, Leadbeater W, Podvin S, Borboa A, Burg M, Sawada R, Rayner J, Sims K, Terasaki T, Johanson C, Stopa E, Eliceiri B, and Baird A
- Subjects
- Animals, Bacteriophages genetics, Epithelial Cells virology, Gene Expression, Genetic Vectors, Immunohistochemistry, Mice, Rats, Transduction, Genetic, Cerebrospinal Fluid virology, Choroid Plexus virology, Epidermal Growth Factor genetics, Gene Transfer Techniques, Genetic Therapy methods
- Abstract
Because the choroid plexus normally controls the production and composition of cerebrospinal fluid and, as such, its many functions of the central nervous system, we investigated whether ligand-mediated targeting could deliver genes to its secretory epithelium. We show here that when bacteriophages are targeted with epidermal growth factor, they acquire the ability to enter choroid epithelial cells grown in vitro as cell cultures, ex vivo as tissue explants or in vivo by intracerebroventricular injection. The binding and internalization of these particles activate EGF receptors on targeted cells, and the dose- and time-dependent internalization of particles is inhibited by the presence of excess ligand. When the phage genome is further reengineered to contain like green fluorescent protein or firefly luciferase under control of the cytomegalovirus promoter, gene expression is detectable in the choroid plexus and ependymal epithelium by immunohistochemistry or by noninvasive imaging, respectively. Taken together, these data support the hypothesis that reengineered ligand-mediated gene delivery should be considered a viable strategy to increase the specificity of gene delivery to the central nervous system and bypass the blood-brain barrier so as to exploit the biological effectiveness of the choroid plexus as a portal of entry into the brain., (Copyright © 2010 Elsevier B.V. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
27. Traumatic brain injury and intestinal dysfunction: uncovering the neuro-enteric axis.
- Author
-
Bansal V, Costantini T, Kroll L, Peterson C, Loomis W, Eliceiri B, Baird A, Wolf P, and Coimbra R
- Subjects
- Animals, Blotting, Western, Brain Injuries physiopathology, Gastrointestinal Diseases metabolism, Gastrointestinal Diseases physiopathology, Ileum physiopathology, Male, Membrane Proteins metabolism, Mice, Mice, Inbred BALB C, Occludin, Permeability, Phosphoproteins metabolism, Statistics, Nonparametric, Tight Junctions metabolism, Zonula Occludens-1 Protein, Brain Injuries complications, Gastrointestinal Diseases etiology, Ileum metabolism
- Abstract
Traumatic brain injury (TBI) can lead to several physiologic complications including gastrointestinal dysfunction. Specifically, TBI can induce an increase in intestinal permeability, which may lead to bacterial translocation, sepsis, and eventually multi-system organ failure. However, the exact mechanism of increased intestinal permeability following TBI is unknown. We hypothesized that expression of tight junction protein ZO-1 and occludin, responsible for intestinal architectural and functional integrity, will decrease following TBI and increase intestinal permeability. BALB/c mice underwent a weight drop TBI model following anesthesia. Brain injury was confirmed by a neurologic assessment and gross brain pathology. Six hours following injury, FITC-dextran (25 mg 4.4 kDa FITC-dextran) was injected into the intact lumen of the isolated ileum. Intestinal permeability was measured in plasma 30 min following injection, by using spectrophotometry to determine plasma FITC-dextran concentrations. Whole ileum extracts were used to measure expression of tight junction proteins ZO-1 and occludin by Western blot. TBI caused a significant increase in intestinal permeability (110.0 microg/mL +/-22.2) compared to sham animals (29.4 microg/mL +/- 9.7) 6 h after injury (p = 0.016). Expression of ZO-1 was decreased by 49% relative to sham animals (p < 0.02), whereas expression of occludin was decreased by 73% relative to sham animals (p < 0.001). An increase in intestinal permeability corresponds with decreased expression of tight junction proteins ZO-1 and occludin following TBI. Expression of intestinal tight junction proteins may be an important factor in gastrointestinal dysfunction following brain injury.
- Published
- 2009
- Full Text
- View/download PDF
28. The deployment of adenovirus-containing gene activated matrices onto severed axons after central nervous system injury leads to transgene expression in target neuronal cell bodies.
- Author
-
Gonzalez AM, Berlanga O, Leadbeater WE, Cooper-Charles L, Sims K, Logan A, Eliceiri B, Berry M, and Baird A
- Subjects
- Animals, Axons pathology, Cell Line, Cell Survival, DNA, Viral metabolism, Green Fluorescent Proteins metabolism, Humans, Optic Nerve pathology, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Rats, Wistar, Retinal Ganglion Cells metabolism, Retinal Ganglion Cells pathology, Adenoviridae genetics, Axons metabolism, Biocompatible Materials metabolism, Central Nervous System pathology, Genetic Therapy, Transcriptional Activation, Transgenes genetics
- Abstract
Background: In previous studies, we showed that gene activated matrices (GAMs) containing nonviral vectors successfully deliver genes to neurons after optic nerve and spinal cord injury. In the present study, we evaluated whether adenoviral vectors delivered within a GAM increase the efficiency of local gene delivery to injured CNS neurons. Lyophilized GAMs containing collagen and adenoviral vectors were assessed in vitro and in vivo., Methods: We evaluated viral vector stability, release kinetics and efficiency of transduction for this GAM formulation in vitro using the quantitative polymerase chain reaction (qPCR), flow cytometry and fluorescence microscopy. Using PCR, reverse transcriptase-PCR and confocal microscopy, we assessed viral DNA retrograde axonal transport, green fluorescent protein (GFP) expression in retinal ganglion cells (RGCs) after GAM implantation into the wound of the rat transected optic nerve., Results: qPCR analyses demonstrated that 100% of viral particles were retained within the collagen after lyophilization. In vitro studies demonstrated that 60% of the particles within the GAM were infective and not released from the collagen matrix when placed in water. By 24 h, GFP expression was detected within cells that have invaded the GAM. In vivo studies demonstrated that adenoviral particles were retrogradely transported in axons from the GAM implanted at the lesion site to the RGC in the retina where the corresponding mRNA was expressed. Analysis of the efficiency of cell transduction indicated that 69% of RGC express GFP., Conclusions: These studies demonstrate that lyophilized GAMs containing adenoviral particles within collagen are stable, retain a significant proportion of their infectivity and successfully and efficiently deliver genes to neurons after central nervous system injury.
- Published
- 2009
- Full Text
- View/download PDF
29. Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins.
- Author
-
Costantini TW, Loomis WH, Putnam JG, Drusinsky D, Deree J, Choi S, Wolf P, Baird A, Eliceiri B, Bansal V, and Coimbra R
- Subjects
- Animals, Burns drug therapy, Burns pathology, Burns physiopathology, Ileum drug effects, Ileum pathology, Male, Membrane Proteins metabolism, Mice, Mice, Inbred BALB C, Microscopy, Confocal, Pentoxifylline pharmacology, Permeability drug effects, Tight Junctions drug effects, Tumor Necrosis Factor-alpha metabolism, Burns etiology, Phosphodiesterase Inhibitors therapeutic use, Tight Junctions physiology
- Abstract
Loss of intestinal barrier function after burn injury allows movement of intraluminal contents across the mucosa, which can lead to the development of distant organ injury and multiple organ failure. Tight junction function is highly regulated by membrane-associated proteins including occludin and zonula occludens protein 1 (ZO-1), which can be modulated by systemic inflammation. We hypothesized that (1) burn injury leads to gut barrier injury, and (2) phosphodiesterase inhibition will attenuate these burn-induced changes. Male balb/c mice undergoing a 30% steam burn were randomized to resuscitation with normal saline or normal saline + pentoxifylline (PTX; 12.5 mg/kg). Intestinal injury was assessed by histological diagnosis and TNF-alpha levels using enzyme-linked immunosorbent assay. Intestinal permeability was assessed by measuring the plasma concentration of fluorescein isothiocyanate-dextran after intraluminal injection in the distal ileum. Occludin and ZO-1 levels were analyzed by immunoblotting and immunohistochemistry. Thirty percent total body surface area (TBSA) burn results in a significant increase in intestinal permeability. Treatment with PTX after burn attenuates intestinal permeability to sham levels. Burn injury resulted in a marked decrease in the levels of tight junction proteins occludin and ZO-1 at 6 and 24 h. The use of PTX after burn significantly decreases the breakdown of occludin and ZO-1. Pentoxifylline also attenuates the burn-induced increase in plasma and intestinal TNF-alpha. Confocal microscopy demonstrates that PTX attenuates the burn-induced reorganization of occludin and ZO-1 away from the tight junction. Pentoxifylline attenuates burn-induced intestinal permeability and decreases the breakdown and reorganization of intestinal occludin and ZO-1. Therefore, phosphodiesterase inhibition may be a useful adjunct strategy in the attenuation of burn-induced gut barrier injury.
- Published
- 2009
- Full Text
- View/download PDF
30. Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis.
- Author
-
Hayashi M, Fearns C, Eliceiri B, Yang Y, and Lee JD
- Subjects
- Amino Acid Sequence, Animals, Carcinoma, Lewis Lung enzymology, Carcinoma, Lewis Lung pathology, Cell Movement drug effects, Endothelial Cells cytology, Endothelial Cells enzymology, Endothelial Cells metabolism, Fibroblast Growth Factor 2 pharmacology, Humans, Melanoma, Experimental enzymology, Melanoma, Experimental pathology, Mice, Mice, Knockout, Mitogen-Activated Protein Kinase 7 deficiency, Molecular Sequence Data, Phosphorylation, Ribosomal Protein S6 Kinases, 90-kDa metabolism, Ribosomal Proteins metabolism, Transplantation, Heterologous, Vascular Endothelial Growth Factor A pharmacology, Carcinoma, Lewis Lung blood supply, MAP Kinase Signaling System physiology, Melanoma, Experimental blood supply, Mitogen-Activated Protein Kinase 7 metabolism, Neovascularization, Pathologic enzymology
- Abstract
Although big mitogen-activated protein kinase 1 (BMK1) has been shown to be critical for embryonic angiogenesis, the role of BMK1 in tumor-associated neovascularization is poorly understood. Exogenous tumors were established in BMK1+/+, BMK1flox/+, or BMK1flox/flox mice carrying the Mx1-Cre transgene. Induced deletion of host BMK1 gene significantly reduced the volumes of B16F10 and LL/2 tumor xenografts in BMK1flox/flox mice by 63% and 72%, respectively. Examining the tumors in these induced BMK1-knockout animals showed a significant decrease in vascular density. Localized reexpression of BMK1 in BMK1-knockout mice by administration of adenovirus encoding BMK1 restored tumor growth and angiogenesis to the levels observed in wild-type mice. These observations were further supported by in vivo Matrigel plug assays in which vascular endothelial growth factor- and basic fibroblast growth factor-induced neovacularization was impaired by removing BMK1. Through screening with the Pepchip microarray, we discovered that in BMK1-knockout endothelial cells, phosphorylation of ribosomal protein S6 (rpS6) at Ser235/236 was mostly abrogated, and this BMK1-dependent phosphorylation required the activity of p90 ribosomal S6 kinase (RSK). Immunofluorescent analysis of tumor vasculature from BMK1-knockout and control animals revealed a strong correlation between the presence of BMK1 and the phosphorylation of rpS6 in tumor-associated endothelial cells of blood vessels. As both RSK and rpS6 are known to be important for cell proliferation and survival, which are critical endothelial cell functions during neovascularization, these findings suggest that the BMK1 pathway is crucial for tumor-associated angiogenesis through its role in the regulation of the RSK-rpS6 signaling module.
- Published
- 2005
- Full Text
- View/download PDF
31. Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure.
- Author
-
Hayashi M, Kim SW, Imanaka-Yoshida K, Yoshida T, Abel ED, Eliceiri B, Yang Y, Ulevitch RJ, and Lee JD
- Subjects
- Animals, Apoptosis, Capillary Permeability, Cell Survival, Fetal Death etiology, MEF2 Transcription Factors, Mice, Mice, Transgenic, Mitogen-Activated Protein Kinase 7, Mitogen-Activated Protein Kinases genetics, Myogenic Regulatory Factors physiology, Recombination, Genetic, Endothelial Cells physiology, Mitogen-Activated Protein Kinases physiology
- Abstract
Big mitogen-activated protein kinase 1 (BMK1), also known as ERK5, is a member of the MAPK family. Genetic ablation of BMK1 in mice leads to embryonic lethality, precluding the exploration of pathophysiological roles of BMK1 in adult mice. We generated a BMK1 conditional mutation in mice in which disruption of the BMK1 gene is under the control of the inducible Mx1-Cre transgene. Ablation of BMK1 in adult mice led to lethality within 2-4 weeks after the induction of Cre recombinase. Physiological analysis showed that the blood vessels became abnormally leaky after deletion of the BMK1 gene. Histological analysis revealed that, after BMK1 ablation, hemorrhages occurred in multiple organs in which endothelial cells lining the blood vessels became round, irregularly aligned, and, eventually, apoptotic. In vitro removal of BMK1 protein also led to the death of endothelial cells partially due to the deregulation of transcriptional factor MEF2C, which is a direct substrate of BMK1. Additionally, endothelial-specific BMK1-KO leads to cardiovascular defects identical to that of global BMK1-KO mutants, whereas, surprisingly, mice lacking BMK1 in cardiomyocytes developed to term without any apparent defects. Taken together, the data provide direct genetic evidence that the BMK1 pathway is critical for endothelial function and for maintaining blood vessel integrity.
- Published
- 2004
- Full Text
- View/download PDF
32. Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1.
- Author
-
Zhong J, Eliceiri B, Stupack D, Penta K, Sakamoto G, Quertermous T, Coleman M, Boudreau N, and Varner JA
- Subjects
- Animals, Calcium-Binding Proteins, Carrier Proteins metabolism, Cell Adhesion Molecules, Endothelial Growth Factors genetics, Hindlimb blood supply, Homeodomain Proteins genetics, Integrins metabolism, Intercellular Signaling Peptides and Proteins genetics, Ischemia physiopathology, Lymphokines genetics, Mice, Mice, Inbred C57BL, Receptors, Vitronectin metabolism, Transcription Factors, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Carrier Proteins genetics, DNA-Binding Proteins, Genetic Therapy, Ischemia therapy, Neovascularization, Physiologic
- Abstract
The ECM protein Del-1 is one of several novel ECM proteins that accumulate around angiogenic blood vessels in embryonic and tumor tissue and promote angiogenesis in the absence of exogenous growth factors. Del-1 expressed in mouse or rabbit ischemic hind-limb muscle by gene transfer rapidly promotes new blood vessel formation and restores muscle function. This angiogenic ECM protein initiates angiogenesis by binding to integrin alphavbeta5 on resting endothelium, thereby resulting in expression of the transcription factor Hox D3 and integrin alphavbeta3. Hox D3 converts resting endothelium to angiogenic endothelium by inducing expression of proangiogenic molecules such as integrin alphavbeta3. These findings provide evidence for an angiogenic switch that can be initiated in the absence of exogenous growth factors and indicate that the angiogenic matrix protein Del-1 may be a useful tool for the therapy of ischemic disease.
- Published
- 2003
- Full Text
- View/download PDF
33. Mechanisms of signal transduction in vascular permeability: potential targets.
- Author
-
Eliceiri B
- Subjects
- Animals, Focal Adhesion Kinase 1, Focal Adhesion Protein-Tyrosine Kinases, Mice, Neoplasms etiology, Neoplasms pathology, Protein-Tyrosine Kinases physiology, Vascular Endothelial Growth Factor A physiology, src-Family Kinases physiology, Capillary Permeability, Signal Transduction
- Published
- 2003
- Full Text
- View/download PDF
34. Amphibian metamorphosis: a complex program of gene expression changes controlled by the thyroid hormone.
- Author
-
Brown DD, Wang Z, Kanamori A, Eliceiri B, Furlow JD, and Schwartzman R
- Subjects
- Amphibians genetics, Amphibians physiology, Animals, Receptors, Thyroid Hormone genetics, Tail growth & development, Xenopus laevis, Amphibians growth & development, Gene Expression Regulation, Developmental, Metamorphosis, Biological genetics, Metamorphosis, Biological physiology, Thyroid Hormones physiology
- Published
- 1995
- Full Text
- View/download PDF
35. Stable integration and expression in mouse cells of yeast artificial chromosomes harboring human genes.
- Author
-
Eliceiri B, Labella T, Hagino Y, Srivastava A, Schlessinger D, Pilia G, Palmieri G, and D'Urso M
- Subjects
- Animals, Blotting, Southern, Cell Line, Genetic Markers, Humans, Mice, Plasmids, Restriction Mapping, Transfection, Chromosomes, Fungal, DNA genetics, DNA, Ribosomal genetics, Glucosephosphate Dehydrogenase genetics, Saccharomyces cerevisiae genetics
- Abstract
We have developed a way to fit yeast artificial chromosomes (YACs) with markers that permit the selection of stably transformed mammalian cells, and have determined the fate and expression of such YACs containing the genes for human ribosomal RNA (rDNA) or glucose-6-phosphate dehydrogenase (G6PD). The YACs in the yeast cell are "retrofitted" with selectable markers by homologous recombination with the URA3 gene of one vector arm. The DNA fragment introduced contains a LYS2 marker selective in yeast and a thymidine kinase (TK) marker selective in TK-deficient cells, bracketed by portions of the URA3 sequence that disrupt the endogenous gene during the recombination event. Analyses of transformed L-M TK- mouse cells showed that YACs containing rDNA or G6PD were incorporated in essentially intact form into the mammalian cell DNA. For G6PD, a single copy of the transfected YAC was found in each of two transformants analyzed and was fully expressed, producing the expected human isozyme as well as the heterodimer composed of the human gene product and the endogenous mouse gene product.
- Published
- 1991
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.